13F
中

XTNT XTANT MEDICAL HOLDINGS INC

2026Q1 · CUSIP 98420P308 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
34
Δ holders QoQ
-2
Breadth percentile
Top 70%
Whale holders
15
Δ whales
0
Inst. holding value
$45M
New positions
5
Closed positions
7
Price momentum (1Q)
—
Put / Call
0/0

Breadth history (34 quarters)

2018Q2: Δ+2 · h=15 2018Q3: Δ+1 · h=16 2018Q4: Δ+0 · h=16 2019Q1: Δ-3 · h=13 2019Q2: Δ+1 · h=14 2019Q3: Δ+1 · h=15 2019Q4: Δ+1 · h=16 2020Q1: Δ+2 · h=18 2020Q2: Δ+1 · h=19 2020Q3: Δ+1 · h=20 2020Q4: Δ+0 · h=20 2021Q1: Δ+2 · h=22 2021Q2: Δ-1 · h=21 2021Q3: Δ-3 · h=18 2021Q4: Δ+5 · h=23 2022Q1: Δ-4 · h=19 2022Q2: Δ+0 · h=19 2022Q3: Δ+0 · h=19 2022Q4: Δ+1 · h=20 2023Q1: Δ+2 · h=22 2023Q2: Δ-2 · h=20 2023Q3: Δ+9 · h=29 2023Q4: Δ+3 · h=32 2024Q1: Δ+2 · h=34 2024Q2: Δ-6 · h=28 2024Q3: Δ+1 · h=29 2024Q4: Δ+2 · h=31 2025Q1: Δ-2 · h=29 2025Q2: Δ+2 · h=31 2025Q3: Δ-1 · h=30 2025Q4: Δ+6 · h=36 2026Q1: Δ-2 · h=34 2018Q2: holders=15 2018Q3: holders=16 2018Q4: holders=16 2019Q1: holders=13 2019Q2: holders=14 2019Q3: holders=15 2019Q4: holders=16 2020Q1: holders=18 2020Q2: holders=19 2020Q3: holders=20 2020Q4: holders=20 2021Q1: holders=22 2021Q2: holders=21 2021Q3: holders=18 2021Q4: holders=23 2022Q1: holders=19 2022Q2: holders=19 2022Q3: holders=19 2022Q4: holders=20 2023Q1: holders=22 2023Q2: holders=20 2023Q3: holders=29 2023Q4: holders=32 2024Q1: holders=34 2024Q2: holders=28 2024Q3: holders=29 2024Q4: holders=31 2025Q1: holders=29 2025Q2: holders=31 2025Q3: holders=30 2025Q4: holders=36 2026Q1: holders=34 -9 -4.5 +0 +4.5 +9 112538 18Q219Q220Q221Q222Q223Q224Q225Q226Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
46.3
EPS (TTM)
$0.01
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
-0.3%
Quarterly Revenue & EPS (4Y)
2022-06-30: $15M 2022-09-30: $14M 2022-12-31: $15M 2023-03-31: $18M 2023-06-30: $20M 2023-09-30: $25M 2023-12-31: $28M 2024-03-31: $28M 2024-06-30: $30M 2024-09-30: $28M 2024-12-31: $32M 2025-03-31: $33M 2025-06-30: $35M 2025-09-30: $33M 2025-12-31: $32M 2026-03-31: $21M 2022-06-30: EPS -0.02 2022-09-30: EPS -0.03 2022-12-31: EPS -0.01 2023-03-31: EPS -0.02 2023-06-30: EPS -0.02 2023-09-30: EPS 0.07 2023-12-31: EPS -0.02 2024-03-31: EPS -0.03 2024-06-30: EPS -0.03 2024-09-30: EPS -0.04 2024-12-31: EPS -0.02 2025-03-31: EPS 0.00 2025-06-30: EPS 0.02 2025-09-30: EPS 0.01 2025-12-31: EPS 0.00 2026-03-31: EPS -0.02 0M 18M 35M $M -0.04 0.02 0.08 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 65 2023-09-30: PE 59.52023-12-31: PE 1062024-03-31: PE 1037629395377848302025-09-30: PE 652025-12-31: PE 19.32026-03-31: PE 46 17 54475543257337050 108951086514674080 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)